A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT01207271
Collaborator
(none)
237
1
2
49.2
4.8

Study Details

Study Description

Brief Summary

The goal of this study is to compare supportive-expressive therapy, a type of psychodynamic psychotherapy, with cognitive therapy for the treatment of depression in community mental health consumers.

Hypothesized mediators of treatment will also be examined.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Therapy
  • Behavioral: Supportive-Expressive Psychodynamic Therapy
N/A

Detailed Description

The goal of this study is to conduct a randomized, comparative, non-inferiority clinical trial that tests the hypothesis that a widely used form of manualized dynamic psychotherapy (supportive-expressive psychodynamic therapy) is not inferior to cognitive therapy when implemented in community mental health settings for the treatment of major depressive disorder (MDD). The specific aims are (1) to conduct a randomized non-inferiority trial to compare supportive-expressive psychodynamic therapy and cognitive therapy for patients with MDD and (2) to assess the comparative effectiveness of supportive-expressive psychodynamic therapy and cognitive therapy on secondary measures of symptoms, patient functioning, and quality of life.

Patient mediators of outcome will also be examined through an additional grant awarded to Paul Crits-Christoph, Ph.D. This grant was funded by the National Institutes of Mental Health

  • RO1MH092363-01. This grant is entitled:"The mechanisms of cognitive and dynamic therapy in community settings."

Recruitment will occur solely through community mental health clinics in and around Philadelphia.

Study Design

Study Type:
Interventional
Actual Enrollment :
237 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Comparison of Cognitive and Dynamic Therapy for MDD in Community Settings
Study Start Date :
Nov 1, 2010
Actual Primary Completion Date :
Dec 9, 2014
Actual Study Completion Date :
Dec 9, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive Therapy

Behavioral: Cognitive Therapy
16 sessions of cognitive therapy administered weekly by a community mental health therapist
Other Names:
  • Cognitive Behavioral Therapy
  • CBT
  • Experimental: Dynamic Therapy

    Behavioral: Supportive-Expressive Psychodynamic Therapy
    16 sessions of supportive-expressive psychodynamic therapy administered weekly by a community mental health therapist
    Other Names:
  • Psychodynamic Psychotherapy
  • Short Term Dynamic Therapy
  • Outcome Measures

    Primary Outcome Measures

    1. Hamilton Rating Scale for Depression (HAM-D) [6 months]

    Secondary Outcome Measures

    1. BASIS-24 [6 months]

    2. Beck Depression Inventory - II (BDI-II) [6 months]

    3. Medical Outcomes Study 36-Item Short Form (SF-36) [6 months]

      Measure of general functionality

    4. Quality of Life Inventory (QOLI) [6 months]

    5. Ways of Responding (WOR) [2 months]

    6. Dysfunctional Attitudes Scale (DAS) [2 months]

    7. Psychological Distance Scaling Task (PDST) [2 months]

    8. Self-Understanding of Interpersonal Patterns Scale-Revised (SUIP-R) [2 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Confirmed diagnosis of major depressive disorder

    • Able to read at the 4th grade level or higher

    • Willingness to be randomized and participate in research

    Exclusion Criteria:
    • Current or past diagnosis of schizophrenia, seizure disorder, bipolar disorder, psychotic features, or clinically significant organic pathology

    • Significant suicidal risk/ideation requiring immediate referral for more intensive treatment, or specific gesture in the last 6 months

    • Current substance abuse or dependence requiring immediate referral to substance abuse program

    • Acute medical problem requiring immediate inpatient treatment

    • Need for referral to a partial hospitalization program

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

    Sponsors and Collaborators

    • University of Pennsylvania

    Investigators

    • Principal Investigator: Mary Beth Gibbons, Ph.D., University of Pennsylvania
    • Principal Investigator: Paul Crits-Christoph, Ph.D., University of Pennsylvania

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Pennsylvania
    ClinicalTrials.gov Identifier:
    NCT01207271
    Other Study ID Numbers:
    • R01HS018440
    First Posted:
    Sep 22, 2010
    Last Update Posted:
    May 2, 2017
    Last Verified:
    Apr 1, 2017
    Keywords provided by University of Pennsylvania
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 2, 2017